Filters
New
Hikma announces settlement agreement for Xyrem® (sodium oxybate) U.S. class action lawsuits
Press Release, Corporate
08 May 2025
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
Press Release, Corporate
08 May 2025
Hikma reiterates full year guidance following good start to the year
Press Release, Corporate
24 April 2025
Inspiring women of Hikma - Meet Nesrine Nouhi, General Manager of Hikma France
Insight, Life at Hikma
17 April 2025
Hikma acquires Novugen’s FDA-approved ANDA for trametinib
Press Release, Product
17 April 2025
Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA
Press Release, Business Development
09 April 2025
New
Hikma launches Cisatracurium Besylate Injection, USP in the US
Press Release, Product
25 March 2025
New
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Press Release, Product
20 March 2025
New
Developing our pipeline in growing therapeutic areas
Story, Corporate
19 March 2025
New
Focusing on our quality manufacturing
Story, Corporate
19 March 2025
New
Expanding our patient reach across our markets
Story, Corporate
19 March 2025
New
Leveraging our role as a leading healthcare provider in MENA
Story, Corporate
19 March 2025
Providing access to clean water for families in Egypt
Story, Responsibility
19 March 2025
Supporting food banks for those in need
Story, Responsibility
19 March 2025
You have viewed 15 of 479 results